drugset
Drugs / PRIM-DJ2727
last change Jun 2025 re-read 3 minutes ago

PRIM-DJ2727

also known as PRIM-DJ2727 - CAPSULES · PRIM-DJ2727 - FROZEN

Other / unclassified

Developed for
Clostridium difficile colitis · ulcerative colitis · constipation disorder · gas bloat syndrome · HIV infectious disease · Klebsiella pneumonia · metabolic dysfunction-associated steatotic liver disease · Parkinson disease
+1 more · alcoholic hepatitis
Investigated by
The University of Texas Health Science Center, Houston · Herbert DuPont, MD · Kelsey Research Foundation

Trials 8

today NCT06827977 · Ph 2 NCT05786404 · Ph 1 NCT04371653 · Ph 2 NCT04373473 · Ph 2 NCT04729790 · Ph 2 NCT03671785 · Ph 1 NCT03329560 · Ph 1
201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 13 trials
Phase 1 NCT05786404 Dec 2023 → Dec 2026 expected ulcerative colitis The University of Texas Health Science Center, Houston Recruiting No outcome recorded
Phase 1 NCT03671785 May 2019 → Oct 2022 Parkinson disease The University of Texas Health Science Center, Houston Completed No outcome recorded
Phase 1 NCT03329560 Apr 2018 → Oct 2019 HIV infectious disease The University of Texas Health Science Center, Houston Completed No outcome recorded
Phase 24 trials
Phase 2 NCT06827977 Mar 2025 → Jun 2027 expected constipation disorder, gas bloat syndrome The University of Texas Health Science Center, Houston Recruiting No outcome recorded
Phase 2 NCT04371653 Dec 2023 → Dec 2024 metabolic dysfunction-associated steatotic liver disease The University of Texas Health Science Center, Houston Withdrawn No outcome recorded Stop: Business
Phase 2 NCT04373473 Sep 2020 → Dec 2026 expected ulcerative colitis The University of Texas Health Science Center, Houston Recruiting No outcome recorded
Phase 2 NCT04729790 Jan 2020 → Jan 2022 Clostridium difficile colitis The University of Texas Health Science Center, Houston Withdrawn No outcome recorded Stop: Business
Phase not stated1 trial
— NCT03786900 — Clostridium difficile colitis, Klebsiella pneumonia Herbert DuPont, MD Available No outcome recorded
Comparator or background therapy3 trials
Phase 1/2 NCT05006430 Comparator Jan 2023 → Jun 2025 overdue alcoholic hepatitis Prasun Kumar Jalal Recruiting No outcome recorded
Phase 1/2 NCT03026231 Comparator Jul 2017 → Jul 2018 Parkinson disease The University of Texas Health Science Center, Houston Withdrawn No outcome recorded
Phase 2 NCT03298048 Comparator Dec 2017 → Mar 2019 Clostridium difficile colitis The University of Texas Health Science Center, Houston Terminated No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 11 sources stand behind the page.

FieldValueCited text
Known as PRIM-DJ2727 “PRIM-DJ2727(microbiota suspension)is an intestinal microbial suspension prepared form stool obtained from carefully and thoroughly screened healthy human donors.” NCT05006430 ↗
10

“PRIM-DJ2727 oral capsules containing lyophilized microbiota product derived from 150 grams of healthy donor stool.” NCT03329560 ↗

“Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727)” NCT03298048 ↗

NCT03026231 ↗

NCT04729790 ↗

NCT04373473 ↗

NCT06827977 ↗

NCT05786404 ↗

NCT04371653 ↗

NCT03671785 ↗

NCT03786900 ↗
Known as PRIM-DJ2727 - CAPSULES “PRIM-DJ2727 - CAPSULES” NCT05786404 ↗
Known as PRIM-DJ2727 - FROZEN “PRIM-DJ2727 - FROZEN” NCT05786404 ↗
Modality Other / unclassified “lyophilized microbiota product” NCT03329560 ↗
Route Oral “PRIM-DJ2727 in orally administered enteric-coated capsules” NCT03026231 ↗